Evidence map

TrialCirculation2021

Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL.

Arjun Majithia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

32 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 34706555